NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 193 filers reported holding NOVAVAX INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,000,000 | +51.1% | 543,724 | +10.1% | 0.01% | +133.3% |
Q2 2018 | $662,000 | +224.5% | 493,820 | +407.3% | 0.00% | +200.0% |
Q1 2018 | $204,000 | +240.0% | 97,341 | +102.8% | 0.00% | – |
Q4 2017 | $60,000 | -40.0% | 48,000 | +238.7% | 0.00% | -100.0% |
Q3 2015 | $100,000 | – | 14,170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |